ARCHIVES

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing

October 8, 2010

Funding Opportunities: NCI Request for Applications

April 28, 2000

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

Clearinghouse Insists On New Dichlorvos Test; CSWG Disagrees

March 24, 1978

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988

Emory Executive Objects to Report On Merit review

July 22, 1977